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1.1. The cardiac action potential and its underlying currents  
The cardiac electrical cycle has been divided into five “phases”. The initial phase (phase 0) 
refers to the fast depolarization of the AP supported by the activation of fast inward Na+ channels (INa). 
Beyond activating other currents of the AP (e.g.: Ca2+-current, K+-currents) this phase is responsible 
for the rapid impulse propagation. The phase 1 reflects a transient repolarization, mainly supported by 
transient outward potassium current (Ito). The magnitude of this phase has important role in shaping 
the spike-and-dome configuration of the AP. Since the expression level of ion channel(s) carrying Ito 
exerts marked differences across the ventricular wall (and therefore the amplitude of Ito as well) the 
spike-and-dome configuration can be considered a specific “marker” in identifying the ventricular 
origin of the cell. The phase 2 also named “plateau phase”, which is a characteristic feature of the 
cardiac AP. During this phase the inward and outward currents transiently balance each other, 
providing a long-lasting isoelectric phase, which has crucial role in cell contraction. Thus ICaL is an 
important player not only in shaping the action potential, but in initiation of intracellular Ca2+ cycle. 
When ICaL slowly decays, the outward K+-currents overcome the charge influx, allowing repolarization 
(phase 3). During the initial section of phase 3, the rapid and slow components of delayed rectifiers 
(IKr and IKs) support large outward K+-current having crucial role in repolarization, while in the 
terminal phase of the AP, the inward rectifier K+ current (IK1) has primary function in the complete 
repolarization. The phase 4 represents the resting membrane potential during diastole. Mainly IK1 and 
perhaps the Na+/K+ pump has important role in maintaining the stable resting membrane potential in 
ventricular cells. In atrial and Purkinje cells, where the expression level of IK1 is significantly smaller, 
the resting membrane potential is unstable, and a slow depolarization can be observable (diastolic 
depolarization), which has important role in the pacemaker function.  
1.1.1. The concept and role of the repolarization reserve 
The concept of the repolarization reserve was introduced by Roden, based on clinical 
observations. Based on clinical and experimental observation it was concluded that in the mammalian 
(human, dog and rabbit) ventricular muscle, inhibition of one type of potassium channels does not 
cause excessive APD lengthening. This is probably due to the capability of the various potassium 
channels which are able to substitute and/or supplement each other. Human, dog and rabbit ventricular 
myocytes seem to repolarize with a strong safety margin (“repolarization reserve”). This repolarization 
capacity has important role in decreasing the transmural APD dispersion, thus in preventing life-
treating arrhythmias. When this normal repolarization reserve is attenuated due to drug exposures 
(cardiac and non-cardiac drugs as well), remodelling caused by diseases (heart failure, diabetes 
mellitus, hypothyroidism, etc), increased sympathetic activity, extreme bradycardia, hypokalaemia or 
genetic disorders (long QT syndromes, Brugada, etc), the otherwise minimal or moderate potassium 
current inhibition can result in excessive and potentially proarrhythmic prolongation of the ventricular 
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action potential duration. Multiple K+ channel block can result in excessive repolarization lengthening 
by eliminating the repolarization reserve and therefore it can be associated with increased 
proarrhythmic risk. 
1.1.2. Transmural heterogeneity in the ventricular myocardium 
Studies described important electrophysiological and pharmacological regional differences of 
ventricular myocardium in mammalian heart. We can distinguish four functional cell types in the 
ventricles: epicardial, midmyocardial, endocardial and Purkinje cells. Epicardial and endocardial cells 
have shorter AP than midmyocardial cells. In epicardium the Ito and IKs are more abundantly expressed 
than in other layers. Midmyocardial cells (M cells) have intermediate electrophysiological features 
compared with Purkinje cells and its pharmacological responses are different from those of either 
epicardium or endocardium. Compared with the epicardium and endocardium, the M cells can be 
characterized by lowest IKs and highest INaL expression levels, pronounced frequency dependence of 
the APD, and marked effect of potassium inhibitions on repolarization. The M cells are well coupled 
electrically with the epicardium and endocardium to stabilize and compensate for the extreme APD 
lengthening. The ICaL, IKr and IK1 are similar in the cardiac layers, but sodium/calcium exchanger 
(NCX) may exhibit the most abundant expression level in M cells. 
1.2. Function of the sodium/calcium exchanger in the heart 
1.2.1. Physiological role of NCX in ventricular myocardium 
NCX is an important contributor to the Ca2+ homeostasis in the myocardium, having a crucial 
role in Ca2+ extrusion from the cell. The NCX is tightly regulated by the transmembrane Na+ and Ca2+ 
gradients and by the actual level of the membrane potential. NCX can operate in a bidirectional 
fashion. In the forward mode NCX extrudes 1 Ca2+ from the cell which is coupled with 3 Na+ ions 
entering the cell. Thus, the forward mode generates inward current, which eventually depolarizes the 
cell membrane. The reverse mode of the NCX is activated when the cytoplasmic Na+ level is increased 
and the Ca2+ concentration is low and/or the membrane potential is depolarized. In this mode the NCX 
extrudes 3 Na+ from the cell and moving 1 Ca2+ into the cell, and it can generate repolarizing net 
current. Under physiologic conditions, NCX operates mainly in forward mode and removes the same 
amount of Ca2+ that entered the cell through ICaL maintaining the beat-to-beat Ca2+ balance. In the same 
time, Ca2+ elimination leads to Na+ influx. In the excitation-contraction coupling (ECC), Ca2+ ions 
enter the cell from the extracellular space (Ca2+-influx) mainly via ICaL. The Ca2+ influx increases the 
Ca2+ concentrations near the ryanodine receptors (RyRs), which triggers Ca2+ release from the 
sarcoplasmic reticulum (SR). This mechanism is called ‘Ca2+-induced Ca2+ release’ (CICR), which 
leads more Ca2+ to be released into the cytosol, resulting in a Ca2+ transient (CaT). In cardiac muscle 
CaTs can be observed as a summary of spatio-temporally restricted Ca2+ sparks, which can be 
monitored by optical (fluorometric) techniques. The free intracellular Ca2+ binds to the myofilaments 
and triggers contraction. After the contraction the released [Ca2+]i is eliminated by both Ca2+ reuptake 
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to the SR via the activity of the SR Ca2+ pump (SERCA2a), and Ca2+ extrusion (efflux) from the cell 
(primarily by the forward mode activity of the NCX). In steady state, during each cycle, the released 
and reuptake Ca2+, as well as the entered and extruded Ca2+ must be equal.  
In the past two decades several NCX inhibitors were developed having different potency and 
selectivity. The KB-R7943 markedly suppressed the NCX current however exerted poor selectivity. 
The SEA0400 is a widely used, potent NCX inhibitor which considerably improved our knowledge 
about the NCX function however a ~ 20% inhibition of ICa made the data interpretation difficult. The 
ORM-10103 and ORM-10962 are recently synthesised, novel NCX inhibitors having an appropriate 
selectivity profile to investigate the NCX function (for details see the chapter 1.3). Theoretically, the 
inhibition of NCX may lead to net gain of the intracellular Ca2+ and causes positive inotropy. This 
effect may have important clinical implication since during heart failure (HF), the Ca2+content of the 
cells is decreased thus the pump function is reduced. However, the possible positive inotropic effect of 
selective NCX inhibition remained controversial in the literature.  Studies performed on rat myocytes 
and Langendorff perfused heart experiments reported clear positive inotropic effect of SEA-0400 
however SEA0400 and ORM-10103 failed to influence the Ca2+ transients in dog ventricular cells. The 
controversial results may be caused by the incomplete selectivity of the applied drugs and/or 
interspecies differences, especially in the kinetics of the action potentials and the intracellular ion 
levels of the cells. 
1.2.2. Possible role of NCX in the pacemaker tissue 
The sinoatrial node (SA node) is the primary pacemaker in the heart generating regular, 
spontaneous APs, to initiate the normal cardiac cycle. Pacemaker potentials are often referred as "slow 
response" action potentials suggesting relatively low kinetics of the ICaT and ICaL during depolarization. 
The upstroke of the AP is preceded by a slow diastolic depolarization (DD), which slowly depolarizes 
the membrane potential to reach the excitation threshold. Any impact, which changes the slope of DD, 
will have an effect on cycle length and heart frequency. Recent works in the atrioventricular node and 
Purkinje cells suggest that the mechanisms governing sino-atrial node automaticity are likely to be 
similar in all pacemaking tissues. During spontaneous pacemaking, several ion channels (If, ICaT, ICaL, 
IK) with finely tuned kinetics cooperate during an action potential waveform, this collective behaviour 
has been termed as “the membrane clock”. Dynamic time- and voltage-dependent interaction of the 
above membrane-limited electrogenic ion channels leads DD from MDP to threshold potential. 
Membrane clock interacting with the intracellular Ca2+ cycling transport mechanism establishes the 
“Ca2+ clock”. The main phenomenon is the spontaneous, periodic local subsarcolemmal Ca2+ release 
(LCRs) from SR during DD in pacemaker cells. These 1-5Hz LCRs activate NCX forward mode, and 
Ca2+ extrusion due to Na+ influx making a depolarizing current. This current may accelerate the DD 
and contribute to spontaneous pacemaking. The two clocks may work synergistically forming a 
coupled-clock system. Previous studies suggested the pivotal role of the NCX in normal automaticity. 
The low-sodium containing bath solution inhibited spontaneous AP firing in guinea-pig SA node cells 
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via suppressing normal function of NCX. Other study reported that depletion of SR store by 
application of ryanodine markedly disturbed the normal pacemaker activity in rabbit SA node cells. 
However, these interventions may have effects on If and ICaL directly, which makes the interpretation 
difficult. Mouse genetic models revealed that partial atrial NCX1 knock out (~90%) caused severe 
bradycardia and other rhythm disorders, while complete atrial NCX knock-out completely suppressed 
the atrial depolarization exerting ventricular escape rhythm on the ECG. The application of KB-
R7943, a non-selective NCX inhibitor, also suppressed spontaneous beating in guinea-pig SA node 
cells; however, it has also effect on the Ca2+-currents. The supposed crucial role of NCX in the normal 
pacemaker function of SA node cells could not be directly challenged experimentally so far, by the 
lack of selective NCX inhibitor.  
1.2.3. Pathophysiological role of NCX in Na+ induced Ca2+ load 
The actual function of the NCX is tightly regulated by the intracellular levels of the Na+ and 
Ca2+ ions.  Therefore, any disturbances, which shift the normal balance of Na+/ Ca2+ handling, will 
influence the NCX function. The altered function of NCX may lead to membrane potential instability 
and development of delayed afterdepolarizations. Several diseases which increase the level of 
intracellular Na+ by reduction of the activity of Na+/K+ pump function (hypoxic conditions or digitalis 
intoxication) or by increasing the INaL (long QT Syndrome 3 – LQT3) can lead to marked activation of 
reverse mode NCX function, which accounts for the concomitant Ca2+ accumulation and the 
subsequent abnormal automaticity. It is suggested that selective NCX inhibition by suppressing either 
the reverse or the forward mode may have antiarrhythmic effect during Na+ induced Ca2+ load. The 
antiarrhythmic effect of selective NCX inhibition is controversial in the literature. NCX inhibitors 
have shown antiarrhythmic effects in hearth rhythm disturbances evoked by ischemia/reperfusion 
injury in vivo, in Langendorff perfused hearts, and in pharmacologically simulated 
ischemia/reperfusion models. The SEA0400 decreased the incidence, and reduced the development of 
EADs, it failed to suppress the aconitine induced arrhythmias. In Langendorff-perfused rat hearts 
SEA0400 even enhanced the arrhythmia incidence and duration. The related studies from our 
laboratory are also contradictory. SEA0400 did not decrease QTc after dofetilide administration, and 
failed to prevent the development of Torsades de Pointes tachyarrhythmias (TdPs) in Langendorff-
perfused rabbit hearts, while in another study it effectively reduced the amplitudes of EADs, without 
influencing APD. In contrast, Milberg et al reported considerable APD shortening effect of SEA0400, 
furthermore, sotalol or veratridine induced TdPs were also suppressed. Recently Jost et al. claimed 
that ORM-10103, a novel NCX inhibitor with improved selectivity decreased pharmacologically 
induced DADs and EADs, confirming previous results performed with SEA0400. 
1.3. Summary of NCX inhibitors 
Benzyloxyphenyl derivative inhibitors like KB-R7943, SEA0400, SN-6 were used 
successfully in several NCX studie. These compounds inhibit NCX from the external side. KB-R7943 
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was the first as a prototype in this NCX inhibitor family, which preferentially inhibits the reverse 
mode operation of NCX. In cardiac cells the reverse mode blocking effect was larger compared with 
the forward mode (EC50= 0.3 µM on reverse vs. 17 µM on forward mode). SEA0400 is a much more 
potent NCX blocker (EC50=111 nM on the reverse vs. 108 nM on the forward mode, , but both KB-
R7943 and SEA0400 were shown to exert substantial nonspecific effects on several ion channels: INa, 
ICaL, IK1 and delayed rectifier K+ currents. SN-6 was developed from KB-R7943, but it also more 
potently inhibits outward, than inward NCX current (EC50= 1.9 µM vs 2.3 µM) and also significantly 
suppresses other currents (INa, ICaL, IKr, IKs, IK1), causing AP shortening. The exchanger inhibitory 
protein (XIP) was developed as NCX inhibitor protein, interacting with the Na+ regulatory domain of 
the NCX and suppresses both transport modes. However, the XIP fails to penetrate through the 
sarcolemma, so it can be used only intracellularly in patch clamp experiments. Recently, novel 
promising NCX inhibitors, ORM-10103 and ORM-10962 have been developed. The ORM-10103 
inhibited both modes of the NCX, and successfully suppressed in vitro the pharmacologically induced 
EADs and DADs in dog heart preparations. With the exception of a 25.4% inhibition of the IKr, the 
ORM-10103 did not influence the major ionic currents. More recently, a novel compound, the ORM-
10962 was synthesized exerting considerably lower EC50 levels with promising selectivity and 
antiarrhythmic profile.  
1.4. Aims of the study 
Since our knowledge about the role of NCX in the cardiac repolarization and in pacemaker 
activity is not fully clarified because of the lack of selective inhibitors, the aims of the present study 
were: 
1) To analyse the effects of the newly synthesized NCX blockers ORM-10103 and ORM-10962 
on the NCX current  
2) To investigate the selectivity of ORM-10962 on major transmembrane ionic currents 
comparing with the results of ORM-10103  
3) To study the effect of selective NCX inhibition on cardiac ventricular action potentials and on 
calcium transients 
4) To investigate the role of NCX in the cardiac pacemaker function 










3.1. Inhibition of NCX current by ORM-10103 and ORM-10962 
ORM-10103 applied at 10 µM concentration caused a comparable, significant inhibition of 
NCX both in the reverse as well as in the forward mode operation (82±9% and 88±6% inhibition, 
respectively, n=6 cell/2 hearts). The estimated EC50 values for the inward and outward NCX currents 
were 780 nM, and 960 nM, however, a small but statistically significant inhibition on the IKr indicated 
the importance of development of novel NCX inhibitor compounds with better selectivity profile and 
lower EC50 values. Therefore, we aimed to analyse the recently synthesized NCX inhibitor compound 
ORM-10962. ORM-10962 considerably decreased both the outward and the inward NCX current in a 
concentration-dependent manner. The effect of the drug at different concentrations on the outward 
NCX current (reverse mode) was calculated at 20 mV and on the inward current (forward mode) was 
determined at -80 mV. The estimated EC50 values of ORM-10962 for the outward and inward NCX 
currents were found to be 67 nM, and 55 nM, respectively. 
3.2. Selectivity of ORM-10962 
3.2.1. The effect of ORM-10962 on the L-type inward calcium current  
The possible effect of ORM-10962 on the ICaL was investigated in single dog ventricular 
myocytes. The following protocol was used for patch clamp measurements: the holding potential was -
80 mV and a short prepulse to -40 mV was added to inactivate INa. ICaL was activated by 400 ms long 
depolarizing voltage pulses to different test potentials ranging from -35 mV to 55 mV. These 
experiments clearly revealed that ORM-10962 even at high (1 µM) concentration did not influence 
ICaL. The effect of ORM-10962 was also studied on slow response action potentials recorded from 
guinea-pig papillary muscles. ORM-10962 at 1 µM did not affect the amplitude or dV/dtmax of the 
slow response action potentials, which may support the results of the direct ICaL measurements. In the 
same preparations for positive control, we used a well-established ICaL blocker nisoldipine at 100 nM, 
which markedly reduced both the amplitude and dV/dtmax of the slow response action potentials. 
3.3.2. The effect of ORM-10962 on late and peak sodium current,  and on Na+/K+ pump 
currents 
The late sodium current (INaL) was activated by depolarizing pulses to -20 mV from a holding 
potential of -120 mV. Addition of 1 µM ORM-10962 did not decrease the amplitude of INaL while 20 
µM TTX completely blocked the current. 
The peak sodium current (INa,peak) was measured in Nav1.5 overexpressed CHO cells at -20 
mV depolarizing pulses from a holding potential of -90 mV. After applying 1 µM ORM-10962 the 
control INa,peak was not significantly changed however, after 20 µM TTX the current markedly reduced. 
The Na+/K+ pump current (Ip) was measured as a steady-state current at -30 mV. In control Ip 
decreased at the end of the 5–7 min incubation with 1 µM ORM-10962. A time control was made in a 
 7 
separate set of experiments when the same protocol was applied with the vehicle of the ORM-10962 
(DMSO). Similar small current decrease was recorded in the steady-state current, which was observed 
in the presence of the ORM-10962. Therefore, it is concluded that ORM-10962 does not influence Ip, 
the slight tendency of the current to decrease is not due to the effect of ORM-10962. For positive 
control 10 µM strophantin was used, which effectively suppressed the current and subsequent addition 
of 0 mM K+ solution failed to cause further decrease in the Na+/K+ pump current justifying the 
complete inhibition of the current after strophantin application. 
3.2.3. The effect of ORM-10962 on outward potassium currents  
The effect of ORM-10962 on IK1, Ito, IKr and IKs were also investigated. The IK1 was measured 
by determining the steady-state current-voltage relationship of the membrane at the end of 300 ms 
long pulses clamped to potentials ranging from -80 to 0 mV. Ito was activated by 1000 ms long 
depolarizing voltage pulses arising from the holding potential of -80 mV to test potentials gradually 
increasing up to 50 mV. IKr and IKs were determined as tail current amplitudes at -40 mV after 
activating these currents by 1000 ms (IKr) or 5000 ms (IKs) long depolarizing voltage pulses at various 
test potentials ranging up to 50 mV. It was found that neither of these currents was significantly 
influenced by 1 µM ORM-10962. 
3.2.4. Selectivity of ORM-10962 on the pacemaker current 
The effect of ORM-10962 on the If was investigated in rabbit right atrial cells isolated from 
the SAN region. The current was activated by hyperpolarizing voltage pulses to -120 mV from the 
holding potential of -30 mV. The pacemaker current was identified as ivabradine sensitive current. At 
negative hyperpolarizing membrane potential (from -30 mV to -120 mV) an ivabradine (10 µM) 
sensitive current could be measured, which was not altered after application of 1 µM ORM-10962. 
3.3. Comparison of the effects of ORM-10103 and ORM-10962 on the major repolarizing 
transmembrane potassium currents  
The IK1, Ito, IKs did not show significant change after application either of 10 µM ORM-10103 
or 1µM ORM-10926. In contrast, 10µM ORM-10103 significantly decreased the IKr amplitude; 
however, 1µM ORM-10962 did not change the current.  
3.4. Effect of selective NCX inhibition on Ca2+ transient and action potentials under normal 
condition 
The amplitude of Ca2+ transients and cell shortening slightly but statistically significantly 
increased after the addition of 1µM ORM-10962. The diastolic Ca2+ did not change significantly 
during the experiment. The characteristic of the AP did not change after application of 1 µM ORM-
10962. 
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3.5. Effect of selective NCX inhibition on endocardial, epicardial tissues and on Purkinje fibres 
In subendocardial multicellular preparation, we observed a moderate increase in the APD 
parameters after application of 1µM ORM-10962, however in subepicardial preparation the APD 
increased significantly. The Purkinje fibre preparations exerted inconsistent and negligible change in 
the action potential duration, where a negative shift of the plateau voltage was observed, without any 
significant changes in the repolarization parameters.  
3.6. Effect of NCX inhibition on the spontaneous automaticity 
3.6.1. Effect of NCX inhibition on spontaneous automaticity on Purkinje fibres and on atrial tissue 
In dog Purkinje fibres 1 µM ORM-10962 exerted clear lengthening effect on the cycle length 
of spontaneous action potentials. In rabbit Purkinje fibres we observed significant cycle lengthening 
effect of spontaneous action potentials after application of 0.5 µM and 1 µM ORM. In rabbit atrial 
measurements, following application of  1µM ORM-10962 moderate but significant lengthening effect 
on the cycle length was observed. The corresponding time control measurements exerted no effect 
after application of the vehicle of ORM-10962 (DMSO). 
3.6.2. Effect of NCX inhibition on spontaneous automaticity after ivabradine treatment 
In this set of experiments 3 µM ivabradine was applied on rabbit right atrial tissue strips to 
reduce spontaneous frequency. The cycle length increased after application of 3 µM and                                    
1 µM ORM-10962 caused further statistically significant increase. ORM-induced increase in the cycle 
length after application of ivabradine was significantly larger compared with the ORM application 
alone. During time control experiments, we found similar effect of ivabradine compared with control, 
but the subsequently applied vehicle (DMSO) failed to influence the cycle length. 
3.7. The antiarrhythmic effect of selective NCX inhibition on delayed afterdepolarizations in 
vitro 
In dog cardiac Purkinje fibres DAD was evoked by 150 nM digoxin, which is a well-known 
Na+/K+ pump inhibitor. After 40 stimuli train with a cycle length of 400 ms, several DAD’s were 
observed during the stimulation-free period. Further addition of 1 µM ORM-10962 significantly 
decreased the DAD’s amplitude. In some of these experiments digoxin evoked a run of extra beats 
(cellular, corresponding to the in vivo extrasystole) after the termination of the stimulus train, which 
could be successfully abolished by the application of 1 µM ORM-10962. 
3.8. Effect of selective NCX inhibition on Ca2+ transient and action potentials when forward or 
reverse mode is facilitated 
In the first set of experiment, extracellular Na+ concentration was decreased to 70 mM, while 
the solution was supplemented with 70 mM choline-cloride thus the lower electrochemical driving 
force for Na+ stimulates the reverse mode of NCX. In these measurements NCX inhibition with 1µM 
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ORM-10962 slightly, but significantly lengthened the repolarization of action potentials. The CaT and 
cell shortening increased by the administration of low Na-Tyrode, and significantly decreased when        
1 µM ORM-10962 was applied. The diastolic Ca2+ significantly decreased after ORM-10962 
application (vs low Na+).   
In another set of experiment, enhanced NCX forward mode was achieved by 1 µM forskolin 
which increases the intracellular Ca2+ level through protein-kinase mediated phosphorylation of the 
ICaL. The plateau voltage of the action potential was significantly depressed after application of 1µM 
ORM-10962 without consistently changing phase 3 repolarization. Application of 600 nM forskolin in 
single ventricular dog myocytes increased the amplitude of transient and cell shortening and addition 
of 1 µM ORM-10962 increased further the amplitudes significantly. The diastolic Ca2+ did not change 
significantly during the experiment.  
 
4. DISCUSSION 
4.1. ORM-10962 exerted improved efficacy and specificity in comparison with ORM-10103 
Previously, the most successfully used NCX inhibitors like KB-R7943 and SEA0400 
considerably improved our knowledge about the role of NCX regarding the electromechanical 
coupling and arrhythmogenesis, but these inhibitors were not appropriately selective i.e. certain 
amount of ICaL and IK currents contaminated the results making the data interpretation difficult. 
Therefore, the most important requirement for a NCX inhibitor – beyond potent blocking of NCX – is 
a minimal influence on the ICaL current. In previous studies of our laboratory, we reported that ORM-
10103 effectively and selectively inhibits NCX in dog ventricular myocytes without influencing the 
ICaL current. Furthermore it was effective against triggered arrhythmias, namely it clearly decreased the 
amplitude of pharmacologically induced EAD and reduced the DAD incidence. However, this 
compound had 25.4% blocking effect on IKr at close to the maximal NCX inhibition concentration 
range. Therefore, this compound has some limitations in studying the role of NCX since it also 
influences the ventricular repolarization. The improved compound, ORM-10962 has no effect on ICaL 
even in higher concentration (1µM) as well as it does not influence the peak and late sodium currents 
and the N+/K+ pump, and the main repolarizing potassium currents like IK1, Ito, IKr and IKs at close the 
maximal NCX inhibition (~80%) concentration range. Furthermore, it has much less EC50 values 
(55/67nM for inward/outward NCX currents, respectively) at both modes of NCX. The better 
selectivity and improved efficacy of ORM-10962 account for performing the further experiments with 
ORM-10962.  
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4.2. Selective NCX inhibition has a moderate positive inotropic effect without major influence on 
the action potential under normal condition 
It is widely accepted that the NCX operates primarily in forward mode during a normal AP, 
therefore, when inhibited, intracellular Ca2+ load, and AP shortening is expected. However, our 
laboratory and others failed to find any influence of SEA0400 and ORM-10103 on AP and CaT. In 
contrast, we observed a marginal but significant increase on CaT and cell shortening after application 
of ORM-10962 in dog ventricular myocytes. Thus, our results support the hypothesis regarding the 
positive inotropic effect of selective NCX inhibition; however, the relatively small extent of the effect 
is unexpected and unclear. A possible explanation could be the concomitant inhibition of reverse mode 
activity which simultaneously decreases the intracellular Ca2+ influx. Further possibility could be the 
PMCA, which may also contribute to Ca2+ extrusion, and therefore it may compensate for the reduced 
NCX function. Based on our previous study, where the NCX was measured in the presence of intact 
Ca2+ cycle, we proposed that under normal condition, the inward NCX current has relatively low 
amplitude thus the inhibition of this small current may be fully compensated by the above mentioned 
mechanisms. The effect of ORM-10962 on AP was investigated in multicellular preparations from 
different transmural regions and showed tissue specific changes. The selective NCX inhibition 
marginally increased the APD90 in epicardial tissue without significant influence on subendocardial 
region and in Purkinje fibres. In healthy myocardium the cells are well coupled electrically, and this 
electronic interaction largely minimizes the repolarization changes at tissue level, while these 
alterations could be augmented at cellular level which may explain the marginal effect in epicardial 
tissue. Previous studies seem to support our suggestion that under normal condition, only small net 
NCX current is evoked during the AP and the influence of the inhibition of this small current may be 
compensated for by the repolarization reserve. The momentary magnitude of NCX current under the 
AP depends on the actual voltage, intracellular Na+ and Ca2+ levels. The kinetics of the APs, CaTs 
may differ regarding the tissue type (subendocardial, subepicardial, Purkinje fibre) and could also be 
different from cell to cell obtained from the same heart region. We cannot rule out the possibility that 
the net current of the NCX is changing throughout the ventricular wall: it becomes inward from epi- to 
endocardial tissue.  
4.3. Selective NCX inhibition decreases the spontaneous pacing rate of SA node and Purkinje 
fibres under normal conditions 
We found significant negative chronotropic effect of ORM-10962 in the SA node and Purkinje 
fibres. Previous studies showed that two competing mechanisms may play a role during the initiation 
of each heartbeat: one is the M (membrane voltage) clock claiming pivotal role of If in determining the 
actual frequency, and the second one is the Ca2+ clock. According to the Ca2+ clock hypothesis, the 
local Ca2+ release from the SR causes local depolarization, which enhances the NCX forward activity. 
Forward NCX due to Ca2+ extrusion generate depolarizing Na+ influx, thus may contribute to the 
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gradual depolarization initiated by the If pacemaker current. Our results seem to be in line with this 
hypothesis, since NCX inhibition by ORM-10962 decreased the spontaneous firing rate in both canine 
and rabbit Purkinje-fibres as well as in rabbit atrial tissue samples. Therefore, NCX inhibition may 
suppress the spontaneous diastolic depolarization and increase the cycle length of the pacemaker cells, 
without directly influencing the If . However, considering these marginal but statistically significant 
effect of ORM-10962, we assume that the NCX may have only a small modulatory role in diastolic 
depolarization. The current theory synthesizes the M-clock and Ca-clock mechanisms, claiming Ca2+-
clock together with M-clock form a coupled-clock system where neither clock is dominant; instead 
together they control the spontaneous AP firing frequency and rhythm in the pacemaker cells. These 
studies showed that ivabradine, however inhibits selectively the If current, it also indirectly suppresses 
Ca2+ cycling by reducing SR Ca2+ load, without direct influence on the ion channels (ICa, RyR) of the 
Ca2+ handling. These results may indicate that the bradycardia occurred by ivabradine is not only the 
consequence of the If blockade alone, but it is rather due to the perturbation of the crosstalk within the 
coupled-clock system. The underlying mechanism may be the reduction in SR load, which leads to 
prolonged local Ca2+ release period, causing reduced and delayed NCX function in the membrane 
clock. Our results may support this crosstalk theory since the AP firing frequency of the ivabradine 
pre-treated spontaneous rabbit atria was further reduced after application of ORM-10962. 
4.4. NCX inhibition is effective against Na+ induced Ca2+ load mediated delayed 
afterdepolarizations 
Previous studies with SEA0400 and ORM-10103 suggested that NCX inhibition could be 
effective against Na+ induced Ca2+ load mediated DADs. The afterdepolarizations were evoked by 
inhibition of Na+/K+ pump by glycosides, leading to accumulation in [Na+]i and AP shortening. The 
elevated intracellular Na+ level induces increased reverse NCX activity causing marked gain in 
intracellular Ca2+ and consequently in the SR Ca2+ level. Selective NCX inhibition by applying ORM-
10962 completely abolished the digoxin induced spontaneous automaticity and significantly decreased 
DADs amplitude. Similar results were observed by application of ORM-10103, where not only DAD, 
but also EAD amplitudes reduced significantly after the ORM-10103 treatment, however this 
compound is not completely selective for NCX. The underlying mechanism of the effect is not exactly 
clarified. During Na+ induced Ca2+ load both modes of the NCX is facilitated by the increased level of 
the Na+ and Ca2+ ions. Therefore, theoretically inhibition of both modes could be antiarrhythmic since 
suppression of the reverse mode may decrease the intracellular Ca2+, while inhibition of forward mode 
may directly reduce the amplitude and incidence of DAD’s amplitude. In order to address this question 
we attempted to selectively facilitate the reverse and mode NCX activity. In the presence of low Na+ 
containing Tyrode’s solution, clear negative inotropic effect could be observed after application of 
ORM-10962 suggesting a decrease in [Ca2+]i level. Furthermore, the APD was marginally but 
statistically significantly lengthened which may also indicate increased reverse mode activity and 
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consequently larger outward current. This result may also suggest that during Na+ induced Ca2+ load 
the NCX operates mainly in reverse mode therefore its inhibition resulted in net loss of intracellular 
Ca2+ and negative inotropy. Similar results were obtained with ORM-10103 in our previous study.  
In a separate experiment, the forward mode was facilitated by forskolin which increases the 
intracellular Ca2+ level via adenylate-cyclase activation. Under this setting the selective NCX 
inhibition caused net gain in intracellular Ca2+ and positive inotropy as well as slight depression in the 
AP plateau potential. The positive inotropy can be explained by the shift of the NCX reverse potential 
caused by increased intracellular Ca2+ which may result in shift to the positive potentials facilitating 
ion transport in the forward mode. The inhibition of the NCX may reduce the rate of the Ca2+ 
extrusion with a concomitant compensatory reduction of the ICaL (the Ca2+ influx and efflux must be 
equal) achieved by the increased Ca2+ transient. This shift in current balance may account (at least 
partially) for the depressed plateau level of the action potential.    
Summarizing these results we suggest that during Na+ induced Ca2+ load both modes 
of the NCX is facilitated but the reverse mode may be predominant during this condition. 
Inhibition of both modes could be theoretically antiarrhythmic. However, the inhibition of the 
reverse mode may have more importance since the net loss of the intracellular Ca2+ may 




















5. CONLUSIONS AND POTENTIAL SIGNIFICANCE 
 
1) We have shown that two newly synthesized NCX inhibitors, ORM-10103 and ORM-10962, 
effectively inhibit both modes of the NCX current. ORM-10962 is more potent than the 
previously described ORM-10103, having the EC50 value of the ORM-10962 in the nanomolar 
range. 
2) ORM-10962 was found a highly selective NCX inhibitor, because even a higher concentration 
(1µM) did not influence other transmembrane ionic currents in the heart (ICaL, INaL, INa peak, 
Na+/K+ pump, IKr, IKs, Ito, IK1, If). However, the ORM-10103 in a higher concentration (10 µM) 
has a moderated IKr blocking effect.  
3) Selective NCX inhibition by ORM-10962 exerted a marginal positive inotropic effect as 
shown by CaT and cell shortening measurements. In the same time, it failed to influence the 
ventricular AP under normal condition.   
4) In line with previous hypothesis we have demonstrated experimentally that NCX has a role in 
the pacemaking mechanisms. The NCX inhibition significantly prolongs the cycle length of 
spontaneous APs recorded from dog and rabbit Purkinje fibres and atrial samples. Moreover, 
addition of ORM-10962 after ivabradine application a further reduction in the spontaneous AP 
firing frequency was observed which may support the coupled-clock hypothesis.  
5) NCX inhibition completely abolished the digoxin-induced automaticity and significantly 
decreased the amplitude of DAD’s. The underlying mechanism was addressed by 
investigating the shifts in the balance of the forward and reverse modes of NCX. When 
forward mode was facilitated, NCX inhibition caused a significant positive inotropic effect 
without major change in APD, however in those experiments in which reverse mode was 
enhanced negative inotropic effect was observed, with APD lengthening. We conclude that 
under Na+ induced Ca2+ load the reverse mode became predominant therefore the subsequently 
applied NCX inhibition decreases the Ca2+ transient amplitude. In line with this, we suggest 
that during digoxin-induced DADs, where also Na+ induced Ca2+ load occurred, the inhibition 
of the facilitated reverse mode may have more importance in the development of 
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